Abstract:Compared to traditional branched polymers with Gd(III) chelates conjugated on their surface, branched polymers with Gd(III) chelates as the internal skeleton are considered to be a reasonable strategy for preparing efficient magnetic resonance imaging contrast agents. Herein, the Gd(III) ligand DOTA was chosen as the internal skeleton; four different molecular weights (3.5, 5.3, 8.6, and 13.1 kDa) and degrees of branching poly-DOTA branched polymers (P1, P2, P3, and P4) were synthesized by a simple "A2 + B4"-type one-pot polymerization. The Gd(III) chelates of these poly-DOTA branched polymers (P1-Gd, P2-Gd, P3-Gd, and P4-Gd) display excellent kinetic stability, which is significantly higher than those of linear Gd-DTPA and cyclic Gd-DOTA-butrol and slightly lower than that of cyclic Gd-DOTA. The T1 relaxivities of P1-Gd, P2-Gd, P3-Gd, and P4-Gd are 29.4, 38.7, 44.0, and 47.9 Gd mM-1 s-1, respectively, at 0.5 T, which are about 6-11 times higher than that of Gd-DOTA (4.4 Gd mM-1 s-1). P4-Gd was selected for in vivo magnetic resonance angiography (MRA) because of its high kinetic stability, T1 relaxivity, and good biosafety. The results showed excellent MRA effect, sensitive detection of vascular stenosis, and prolonged observation window as compared to Gd-DOTA. Overall, Gd(III) chelates of poly-DOTA branched polymers are good candidates of MRI probes, providing a unique design strategy in which Gd chelation can occur at both the interior and surface of the poly-DOTA branched polymers, resulting in excellent relaxivity enhancement. In vivo animal MRA studies of the probe provide possibilities in discovering small vascular pathologies.

Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Arabinogalactan As A Carrier for Contrast Agent in Magnetic Resonance Imaging

Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Synthesis and evaluation of novel polysaccharide-Gd-DTPA compounds as contrast agent for MRI

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Comparison Between Gd-Dtpa and Several Bisamide Derivatives As Potential Mri Contrast Agents

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Synthesis, Relaxivity And Biodistribution Of Novel Magnetic Resonance Imaging (Mri) Contrast Agents: Polylysine (Gd-Dtpa/Dota) With Pendent Galactose Moieties As Hepatocyte-Targeting Groups

Studies on D-galactose-containing DTPA bisamide gadolinium complexes as liver-targeting MRI contrast agents

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

Synthesis and Evaluation of Aromatic Dtpa-Bis(Amide) Gadolinium Complexes As Magnetic Resonance Imaging Contrast Agents

Evaluation of Dendritic Gadolinium Complexes as MRI Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent

A Biocompatible Gadolinium (III)-Poly (Aspartic Acid-Co-Phenylalanine) for Liver Magnetic Resonance Imaging Contrast Agent

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents